Vitals

Does a new Alzheimer’s study hold the secret to early diagnosis?


Alzheimer Disease Alzheimer disease as a neuropathology memory loss due to brain degeneration and decline as a surreal medical neurology illness concept.
By Shanley Pierce | March 4, 2019

Early detection of Alzheimer’s would be the holy grail for aging Americans, as one in 10 people age 65 and older is afflicted with the degenerative brain disease. After decades of costly clinical trials, however, Alzheimer’s research remains riddled with setbacks and failures.

But in February, researchers in Europe and Australia published a study in Science Advances that showed 10 different plasma proteins helped determine which people are likely to develop Alzheimer’s. Individuals with high levels of beta-amyloid in their brains— a protein fragment that accumulates and kills brain cells— were classified as having preclinical Alzheimer’s.

The study, which compared 238 cognitively healthy individuals, offers a glimmer of hope in a field with no survivors.

How could this study improve the detection and treatment of Alzheimer’s in the future?

Previous generations assumed that if individuals were cognitively unimpaired, they didn’t have beta-amyloid in their brains. However, positron emission tomography (PET) scans debunked that notion. Researchers can now capture high-quality images of amyloid plaques in the brain and show the presence of beta-amyloid even in the brains of cognitively healthy patients.

Currently, scientists use PET imaging and cerebrospinal fluid to identify biomarkers in the blood for Alzheimer’s. However, PET imaging is highly expensive and is only available at specialized centers. Spinal taps to extract cerebrospinal fluid, though less expensive, are extremely painful for patients.

A blood test to screen for preclinical Alzheimer’s—much like routine blood tests to measure cholesterol or glucose levels—could be inexpensive and widely available.

“It would be nice if we could draw a blood test when you’re 50 or 60, monitor you every five years, be alerted of your amyloid levels, and [prescribe] a pill or infusion that’s going to help stave off Alzheimer’s,” said Joseph Shimon Kass, M.D., director of neurology at Baylor College of Medicine’s Alzheimer’s Disease and Memory Disorders Center. “We’re nowhere near that, but this study brings us closer to that possibility.”

Given that biological changes occur in the brain 10 to 20 years before there are any clinical symptoms of Alzheimer’s, early detection could also help alleviate the economic burden the disease weighs on the health care system.

“Financially, if all Americans today who have Alzheimer’s or who will get Alzheimer’s were diagnosed in the mild cognitive impairment stage (before they develop full-blown dementia), it could collectively save up to $7.9 trillion in health and long-term care cost,” said Julie Kutac, Ph.D., professional education and research specialist at the Alzheimer’s Association’s Houston & Southeast Texas Chapter.

How is the new blood test different?

Researchers claim that theirs is the first study to consistently use non-targeted techniques to analyze any protein that could potentially serve as a biomarker throughout the different phases of testing. Instead of searching for specific proteins researchers believe are associated with Alzheimer’s, a non-targeted approach can measure many more proteins.

Scientists found 560 proteins associated with beta-amyloid pathology, then narrowed it down to 10 proteins that helped them determine which cognitively unimpaired individuals in the study had high enough levels of beta-amyloid in their brains to qualify as preclinical Alzheimer’s.

What are the caveats of the new study?

This test “probably has some value,” said Joseph C. Masdeu, M.D., Ph.D., director of the Houston Methodist Nantz National Alzheimer Center, but additional studies with larger sample groups will need to be performed to validate these claims.

The European group consisted of 59 participants who were beta-amyloid negative and 35 who were beta-amyloid positive. The Australian group consisted of 100 participants who were beta-amyloid negative and 44 who were beta-amyloid positive.

Although the test had an overall accuracy of 89 percent and positive predictive value (meaning the chances that a patient receives a positive result) of 85 percent, the test groups were too small to make any profound pronouncements.

Nonetheless, this study is a step in the right direction.

“Research on this disease is moving faster now than ever before,” Masdeu said. “The data is coming in very quickly and, with it, the hope that we will very soon have something that we can offer our patients as a treatment.”




Social Posts

profile_image

MD Anderson Cancer Center

@MDAndersonNews

Myth: #Pain is just physical.Learn the truth from our @uzo_md and read his advice for getting the right treatment: https://t.co/wIXQFSImcE #endcancer

1 hour ago
profile_image

Veterans Affairs

@DeptVetAffairs

Tens of thousands of volunteers laid wreaths at VA national cemeteries across the U.S. as part of National Wreaths Across America Day Dec. 14. https://t.co/ENkDR3bqxB

4 hours ago
profile_image

MD Anderson Cancer Center

@MDAndersonNews

“We need to better understand why #probiotics don’t help and may even be harmful,” says our @carrie_d_mac of the microbiome’s link to the effectiveness of #immunotherapy. #endcancer https://t.co/t6fulbhDcH

4 hours ago
profile_image

BCMHouston

@bcmhouston

Learn how Dr. Zachary Pallister stays fit in this week's Healthy Habits. https://t.co/GLO29z2W2u #healthy #habits

5 hours ago
profile_image

Veterans Affairs

@DeptVetAffairs

VA mom helping women Veterans… inspired by her Navy daughter https://t.co/immmo4yLt9 via #VAntagePoint

6 hours ago
profile_image

MD Anderson Cancer Center

@MDAndersonNews

“When I first made eye contact with @MAOnstad, I knew I was where I was supposed to be,” says #uterinecancer survivor Tralisa Woods: https://t.co/iCEfVL0tGj #gyncsm #endcancer

6 hours ago
profile_image

Veterans Affairs

@DeptVetAffairs

VA’s Office of Mental Health and Suicide Prevention supports proposed three-digit dialing code for suicide hotline https://t.co/a6hiRA6I7Q via #VAntagePoint

8 hours ago
profile_image

Memorial Hermann

@memorialhermann

@skologinczak We'd like to hear more about your experience. Please send your contact information and Memorial Hermann location to help@memorialhermann.org so we can look into this.

9 hours ago
profile_image

Memorial Hermann

@memorialhermann

@skologinczak We'd like to hear more about your experience. Please send your contact information and Memorial Hermann location to help@memorialhermann.org so we can look into this.

9 hours ago
profile_image

BCMHouston

@bcmhouston

Wondering what you should be eat to fuel your workout? Registered dietitian, Roberta Anding, breaks it down. https://t.co/BRhtzvO48R #exercise #workouts

9 hours ago
profile_image

Houston Methodist

@MethodistHosp

@Nanomed_hmri Appreciate the share.

10 hours ago
profile_image

Houston Methodist

@MethodistHosp

@RobertaS_CIO @InnoMapHou @nataliejharms Appreciate the shout-out.

10 hours ago
profile_image

Houston Methodist

@MethodistHosp

@lifecourseUofT Thanks for the shout-out.

10 hours ago
profile_image

BCMHouston

@bcmhouston

Dr. Atif Iqbal with @BCM_Surgery discusses the human papillomavirus virus and the rise of anal cancer. https://t.co/GhsLd2flaJ #HPV

11 hours ago
profile_image

University of Houston

@UHouston

RT @UHCougars: .@UHouston students, don't forget to claim your ticket!Don't miss out on a 👔𝘽𝙇𝙐𝙀 𝙎𝙃𝙄𝙍𝙏 𝙍𝙀𝘿 𝙏𝙄𝙀 𝙏-𝙎𝙃𝙄𝙍𝙏!! 🤯🎟️| https://…

1 day ago